IL-17A, which is mainly produced by proinflammatory TH17 cells, is a key mediator of renal and vascular dysfunction in hypertensive mice, correlates with hypertension in humans and constitutes a promising target for new therapeutic approaches, such as IL-17 antibodies, as these agents are already approved for certain autoimmune diseases [74]. The gene discussed is IL17A; the disease is autoimmune disease.